Evidence map›Paper›PMID 36907909›Full record

ArticleScientific reports2023

Computational optimization of delivery parameters to guide the development of targeted Nasal spray.

Jinze Du, Xiecheng Shao, Jean-Marie C Bouteiller, Angela Lu, Isaac Asante, Stan Louie, Mark S Humayun, Gianluca Lazzi

Full text read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jinze Du *Department of Electrical Engineering, University of Southern California, Los Angeles, CA, 90089, USA. jinzedu@usc.edu.
Xiecheng Shao *Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, 90089, USA.
Jean-Marie C BouteillerDepartment of Biomedical Engineering, University of Southern California, Los Angeles, CA, 90089, USA.
Angela LuDepartment of Pharmacy, University of Southern California, Los Angeles, CA, 90089, USA.
Isaac AsanteDepartments of Ophthalmology, University of Southern California, Los Angeles, CA, USA.
Stan LouieDepartments of Ophthalmology, University of Southern California, Los Angeles, CA, USA.
Mark S HumayunDepartment of Biomedical Engineering, University of Southern California, Los Angeles, CA, 90089, USA.
Gianluca LazziDepartment of Electrical Engineering, University of Southern California, Los Angeles, CA, 90089, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Airborne transmission by droplets and aerosols is known to play a critical role in the spread of many viruses amongst which are the common flu and the more recent SARS-CoV-2 viruses. In the case of SARS-CoV-2, the nasal cavity not only constitutes an important viral entry point, but also a primary site of infection (Sungnak W. et al. Nat. Med. 26:681-687. https://doi.org/10.1038/s41591-020-0868-6 , 2020).. Although face masks are a well-established preventive measure, development of novel and easy-to-use prophylactic measures would be highly beneficial in fighting viral spread and the subsequent emergence of variants of concern (Tao K. et al. Nat Rev Genet 22:757-773. https://doi.org/10.1038/s41576-021-00408-x , 2021). Our group has been working on optimizing a nasal spray delivery system that deposits particles inside the susceptible regions of the nasal cavity to act as a mechanical barrier to impede viral entry. Here, we identify computationally the delivery parameters that maximize the protection offered by this barrier. We introduce the computational approach and quantify the protection rate obtained as a function of a broad range of delivery parameters. We also introduce a modified design and demonstrate that it significantly improves deposition, thus constituting a viable approach to protect against nasal infection of airborne viruses. We then discuss our findings and the implications of this novel system on the prevention of respiratory diseases and targeted drug delivery.

Indexed as

COVID-19Nasal SpraysHumansNasal CavityRespiratory Aerosols and DropletsSARS-CoV-2Nasal Sprays

Identifiers

PMID36907909
PMCPMC10008197

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read21
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.